Lastly, down‐regulated FABP5 indicated prolonged survival in WHO grade III gliomas and GBM; however, there was no significant correlation between FABP5 and prognosis in WHO grade II gliomas (Figure 3K,L and Figure S3C). The gene discussed is FABP5; the disease is central nervous system cancer.